|
1
|
Yao JC, Eisner MP, Leary C, Dagohoy C,
Phan A, Rashid A, Hassan M and Evans DB: Population-based study of
islet cell carcinoma. Ann Surg Oncol. 14:3492–3500. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yao JC, Hassan M, Phan A, Dagohoy C, Leary
C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, et al:
One hundred years after ‘carcinoid’: Epidemiology of and prognostic
factors for neuroendocrine tumors in 35,825 cases in the United
States. J Clin Oncol. 26:3063–3072. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Song L, Webb NE, Song Y and Tuan RS:
Identification and functional analysis of candidate genes
regulating mesenchymal stem cell self-renewal and multipotency.
Stem Cells. 24:1707–1718. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yao JC, Shah MH, Ito T, Bohas CL, Wolin
EM, Van Cutsem E, Hobday TJ, Okusaka T, Capdevila J, de Vries EG,
et al: RAD001 in Advanced Neuroendocrine Tumors, Third Trial
(RADIANT-3) Study Group: Everolimus for advanced pancreatic
neuroendocrine tumors. N Engl J Med. 364:514–523. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Strosberg JR, Cheema A, Weber JM, Ghayouri
M, Han G, Hodul PJ and Kvols LK: Relapse-free survival in patients
with nonmetastatic, surgically resected pancreatic neuroendocrine
tumors: An analysis of the AJCC and ENETS staging classifications.
Ann Surg. 256:321–325. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
de Herder WW: Gastroenteropancreatic
neuroendocrine tumors (GEP-NETs). Best Pract Res Clin
Gastroenterol. 26:689–690. 2012. View Article : Google Scholar
|
|
7
|
Miletti-González KE, Chen S, Muthukumaran
N, Saglimbeni GN, Wu X, Yang J, Apolito K, Shih WJ, Hait WN and
Rodríguez-Rodríguez L: The CD44 receptor interacts with
P-glycoprotein to promote cell migration and invasion in cancer.
Cancer Res. 65:6660–6667. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Baccelli I and Trumpp A: The evolving
concept of cancer and metastasis stem cells. J Cell Biol.
198:281–293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma I and Allan AL: The role of human
aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell
Rev. 7:292–306. 2011. View Article : Google Scholar
|
|
12
|
Ginestier C, Hur MH, Charafe-Jauffret E,
Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG,
Liu S, et al: ALDH1 is a marker of normal and malignant human
mammary stem cells and a predictor of poor clinical outcome. Cell
Stem Cell. 1:555–567. 2007. View Article : Google Scholar
|
|
13
|
Luo Y, Dallaglio K, Chen Y, Robinson WA,
Robinson SE, McCarter MD, Wang J, Gonzalez R, Thompson DC, Norris
DA, et al: ALDH1A isozymes are markers of human melanoma stem cells
and potential therapeutic targets. Stem Cells. 30:2100–2113. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gaur P, Sceusi EL, Samuel S, Xia L, Fan F,
Zhou Y, Lu J, Tozzi F, Lopez-Berestein G, Vivas-Mejia P, et al:
Identification of cancer stem cells in human gastrointestinal
carcinoid and neuroendocrine tumors. Gastroenterology.
141:1728–1737. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Miyazaki J, Araki K, Yamato E, Ikegami H,
Asano T, Shibasaki Y, Oka Y and Yamamura K: Establishment of a
pancreatic beta cell line that retains glucose-inducible insulin
secretion: Special reference to expression of glucose transporter
isoforms. Endocrinology. 127:126–132. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ogawa K, Tanaka S, Matsumura S, Murakata
A, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N, Tanabe M, et al:
EpCAM-targeted therapy for human hepatocellular carcinoma. Ann Surg
Oncol. 21:1314–1322. 2014. View Article : Google Scholar
|
|
17
|
Adikrisna R, Tanaka S, Muramatsu S, Aihara
A, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N, Yamaoka S, et al:
Identification of pancreatic cancer stem cells and selective
toxicity of chemotherapeutic agents. Gastroenterology.
143:234–45.e7. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Muramatsu S, Tanaka S, Mogushi K,
Adikrisna R, Aihara A, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N,
et al: Visualization of stem cell features in human hepatocellular
carcinoma reveals in vivo significance of tumor-host interaction
and clinical course. Hepatology. 58:218–228. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yoshitake K, Tanaka S, Mogushi K, Aihara
A, Murakata A, Matsumura S, Mitsunori Y, Yasen M, Ban D, Noguchi N,
et al: Importin-α1 as a novel prognostic target for hepatocellular
carcinoma. Ann Surg Oncol. 18:2093–2103. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ishizawa K, Rasheed ZA, Karisch R, Wang Q,
Kowalski J, Susky E, Pereira K, Karamboulas C, Moghal N,
Rajeshkumar NV, et al: Tumor-initiating cells are rare in many
human tumors. Cell Stem Cell. 7:279–282. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tanaka S, Pero SC, Taguchi K, Shimada M,
Mori M, Krag DN and Arii S: Specific peptide ligand for Grb7 signal
transduction protein and pancreatic cancer metastasis. J Natl
Cancer Inst. 98:491–498. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yoshida Y, Takahashi K, Okita K, Ichisaka
T and Yamanaka S: Hypoxia enhances the generation of induced
pluripotent stem cells. Cell Stem Cell. 5:237–241. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Z, Bao S, Wu Q, Wang H, Eyler C,
Sathornsumetee S, Shi Q, Cao Y, Lathia J, McLendon RE, et al:
Hypoxia-inducible factors regulate tumorigenic capacity of glioma
stem cells. Cancer Cell. 15:501–513. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang B: CD73: A novel target for cancer
immunotherapy. Cancer Res. 70:6407–6411. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Stagg J, Divisekera U, McLaughlin N,
Sharkey J, Pommey S, Denoyer D, Dwyer KM and Smyth MJ: Anti-CD73
antibody therapy inhibits breast tumor growth and metastasis. Proc
Natl Acad Sci USA. 107:1547–1552. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chojnacki A and Weiss S: Production of
neurons, astrocytes and oligodendrocytes from mammalian CNS stem
cells. Nat Protoc. 3:935–940. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai
P, Chu PW, Lam CT, Poon RT and Fan ST: Significance of
CD90+ cancer stem cells in human liver cancer. Cancer
Cell. 13:153–166. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Keith B and Simon MC: Hypoxia-inducible
factors, stem cells, and cancer. Cell. 129:465–472. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mimeault M and Batra SK: Hypoxia-inducing
factors as master regulators of stemness properties and altered
metabolism of cancer- and metastasis-initiating cells. J Cell Mol
Med. 17:30–54. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mahmood A, Harkness L, Abdallah BM,
Elsafadi M, Al-Nbaheen MS, Aldahmash A and Kassem M: Derivation of
stromal (skeletal and mesenchymal) stem-like cells from human
embryonic stem cells. Stem Cells Dev. 21:3114–3124. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chamberlain G, Fox J, Ashton B and
Middleton J: Concise review: mesenchymal stem cells: their
phenotype, differentiation capacity, immunological features, and
potential for homing. Stem Cells. 25:2739–2749. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bussolati B, Bruno S, Grange C, Ferrando U
and Camussi G: Identification of a tumor-initiating stem cell
population in human renal carcinomas. FASEB J. 22:3696–3705. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Eltzschig HK, Köhler D, Eckle T, Kong T,
Robson SC and Colgan SP: Central role of Sp1-regulated CD39 in
hypoxia/ischemia protection. Blood. 113:224–232. 2009. View Article : Google Scholar :
|
|
34
|
Stagg J and Smyth MJ: Extracellular
adenosine triphosphate and adenosine in cancer. Oncogene.
29:5346–5358. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Antonioli L, Blandizzi C, Pacher P and
Haskó G: Immunity, inflammation and cancer: A leading role for
adenosine. Nat Rev Cancer. 13:842–857. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Beavis PA, Slaney CY, Milenkovski N,
Henderson MA, Loi S, Stagg J, Kershaw MH and Darcy PK: CD73: A
potential biomarker for anti-PD-1 therapy. OncoImmunology.
4:e10466752015. View Article : Google Scholar : PubMed/NCBI
|
